title: Hepatic disorders. Features and appropriate management.
abstract: The spectrum of liver disease is extremely wide, with many of the underlying disorders having acute and chronic presentations. Most of the underlying pathogenetic mechanisms are accounted for by autoimmune disease, viral infection and toxic insult. The management strategy of any liver disease is a combination of treating the symptoms and complications that arise, as well as drug therapies relevant to the specific underlying diagnosis. Encephalopathy, ascites, spontaneous bacterial peritonitis, variceal bleeding and pruritus are the main complications at which drug therapy is directed, although in some cases it represents only 1 aspect of the overall management. Drug therapy per se is largely ineffective in acute liver failure with the possible exception of acetylcysteine, but many drugs are used in the management of the constituent components of this complex medical emergency. Treatments for specific liver conditions are expanding, especially in the areas of autoimmune and viral disease. The increasing availability and success of liver transplantation has tended to change the emphasis of management, and it is often not appropriate to exhaust the treatment options before referring the patient for transplantation. A comprehensive review of all liver disease is beyond the scope of this article, but hopefully the important principles of management and commonly occurring clinical decisions are discussed.
authors.affiliation: Liver Unit, St James's University Hospital, Leeds, England.
authors.forename: M A
authors.initials: MA
authors.lastname: Aldersley
authors.forename: J G
authors.initials: JG
authors.lastname: O'Grady
mesh_terms: D001201:Ascites / Q000628:therapy; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000601:surgery; D015209:Cholangitis, Sclerosing / Q000188:drug therapy; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy / Q000601:surgery; D006501:Hepatic Encephalopathy / Q000188:drug therapy / Q000209:etiology; D006509:Hepatitis B / Q000188:drug therapy; D006527:Hepatolenticular Degeneration / Q000188:drug therapy; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000150:complications / Q000628:therapy*; D008107:Liver Diseases / Q000150:complications / Q000188:drug therapy*; D008108:Liver Diseases, Alcoholic / Q000188:drug therapy; D017114:Liver Failure, Acute / Q000150:complications*; D010538:Peritonitis / Q000188:drug therapy; D011537:Pruritus / Q000188:drug therapy